UNSPSC 51334000: Antipsychotic spiro compounds

Antipsychotic drugs made from a group of compounds consisting in part of two rings sharing one carbon atom in common.

UNSPSC 51334000 Antipsychotic spiro compounds is a Class code that does not align with the state and local procurement activity currently tagged under it. The recent opportunities solicited under this code involve naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which fall within the scope of antipsychotic medications or spiro-compound chemistry. The mismatch suggests either miscoding in the state and local databases or a taxonomy misalignment between UNSPSC and issuing-body classification practices. The code shows no recent activity reflecting its nominal scope.

Issuing bodies posting opportunities tagged to this code include Seminole County, Florida (health department-level community health procurement), the Texas Health and Human Services Commission (state agency pharmacy program innovation), and the Minnesota Multistate Cooperative Purchasing Alliance (multi-state collaborative framework administered by Minnesota's Office of State Procurement). Activity clusters in Florida and the upper Midwest, with Texas representing preliminary market intelligence rather than active competitive procurement. Seminole County released an IFB on June 30, 2026 (due July 26, 2023—a data anomaly) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building. Texas HHS issued an RFI on April 3, 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs. Minnesota MMCAP posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, requiring vendors to work through three authorized wholesalers and submit detailed product information with specific National Drug Codes by the February 18, 2026 question deadline.